Common variable immunodeficiency (CVID) — presentation & management
Antibody deficiency with recurrent infection and immune dysregulation · Allergy / Immunology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
CVID is the commonest symptomatic primary antibody deficiency, presenting in adolescence or adulthood with recurrent sinopulmonary infections, low IgG with low IgA and/or IgM, and poor vaccine responses. Beyond infection it causes autoimmunity, granulomatous disease, enteropathy and increased lymphoma risk, and is treated with immunoglobulin replacement.
Red flags
- Recurrent pneumonia with evolving bronchiectasis
- Unexplained cytopenias (autoimmune haemolysis/thrombocytopenia)
- Persistent lymphadenopathy or splenomegaly (lymphoma risk)
- Chronic diarrhoea and weight loss (enteropathy)
- Granulomatous lung or liver disease
Assessment
Differential diagnosis
- Secondary hypogammaglobulinaemia (drugs, protein loss, malignancy)
- Specific antibody deficiency with normal immunoglobulins
- Selective IgA deficiency
- X-linked agammaglobulinaemia (earlier onset, absent B cells)
- Good syndrome (thymoma with immunodeficiency)
Investigations
- Serum immunoglobulins (low IgG with low IgA and/or IgM)
- Vaccine response testing (protein and polysaccharide antigens)
- Lymphocyte subsets (B-cell numbers, switched memory B cells)
- Exclude secondary causes (protein loss, drugs, myeloma, HIV)
- CT chest for bronchiectasis and imaging for lymphoproliferation/granuloma
Management
- Suspect CVID in recurrent sinopulmonary infections with low immunoglobulins beyond infancy
- Confirm low IgG with low IgA/IgM and impaired vaccine responses
- Exclude secondary causes of hypogammaglobulinaemia
- Treat acute infections promptly with appropriate antibiotics and seek atypical organisms
- Start immunoglobulin replacement to achieve a protective trough IgG level
- Screen for and manage complications: bronchiectasis, autoimmune cytopenias, enteropathy, granulomatous disease
- Avoid live vaccines and ensure household contacts are vaccinated
- Manage long term in a specialist immunology centre with surveillance for lymphoma
Drugs & doses
Immunoglobulin replacement — IVIG 0.4-0.6 g/kg every 3-4 weeks, or subcutaneous equivalent weekly, titrated to trough IgG
Co-amoxiclav — 625 mg orally three times daily for acute bacterial infection
Prophylactic azithromycin — 250 mg orally three times weekly in selected patients with bronchiectasis
Prednisolone — 1 mg/kg orally for immune-mediated complications (specialist use)
Disposition
Manage in a specialist immunology service with immunoglobulin replacement and complication surveillance; admit severe acute infections.
Complications & pitfalls
- Bronchiectasis and chronic lung disease
- Autoimmune cytopenias and other autoimmunity
- Granulomatous-lymphocytic interstitial lung disease
- Enteropathy and malabsorption
- Increased lymphoma and gastric cancer risk
Exam pearls
- Diagnose only after excluding secondary causes of low immunoglobulins
- CVID is about immune dysregulation as much as infection — screen for autoimmunity and malignancy
- Immunoglobulin replacement is titrated to a protective trough and to clinical infection control
- Avoid live vaccines and vaccinate close contacts
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.